These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38750771)

  • 1. Lipid levels correlate with neuronal and dopaminergic markers during the differentiation of SH-SY5Y cells.
    Marlet FR; Muñoz SS; Sotiraki N; Eliasen JN; Woessmann J; Weicher J; Dreier JE; Schoof EM; Kohlmeier KA; Maeda K; Galvagnion C
    Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167212. PubMed ID: 38750771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Characterization of Phenotypical Markers After Differentiation of SH-SY5Y Cells.
    Ducray AD; Wiedmer L; Herren F; Widmer HR; Mevissen M
    CNS Neurol Disord Drug Targets; 2020; 19(8):618-629. PubMed ID: 32640966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
    Xie HR; Hu LS; Li GY
    Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelet lysate supports SH-SY5Y neuroblastoma cell proliferation and differentiation into a dopaminergic-like neuronal phenotype under xenogeneic-free culture conditions.
    Ribeiro M; Campos J; Pinho TS; Sampaio-Marques B; Barata-Antunes S; Cibrão JR; Araújo R; Duarte-Silva S; Moreira E; Sousa RA; Costa PM; Salgado AJ
    Biotechnol J; 2024 Jul; 19(7):e2400068. PubMed ID: 38987218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
    Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
    Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach.
    Magalingam KB; Somanath SD; Ramdas P; Haleagrahara N; Radhakrishnan AK
    J Mol Neurosci; 2022 May; 72(5):1026-1046. PubMed ID: 35258800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recapitulating Parkinson's disease pathology in a three-dimensional human neural cell culture model.
    Taylor-Whiteley TR; Le Maitre CL; Duce JA; Dalton CF; Smith DP
    Dis Model Mech; 2019 Apr; 12(4):. PubMed ID: 30926586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease cybrids, differentiated or undifferentiated, maintain morphological and biochemical phenotypes different from those of control cybrids.
    Appukuttan TA; Ali N; Varghese M; Singh A; Tripathy D; Padmakumar M; Gangopadhyay PK; Mohanakumar KP
    J Neurosci Res; 2013 Jul; 91(7):963-70. PubMed ID: 23653325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson's Disease.
    Xicoy H; Brouwers JF; Kalnytska O; Wieringa B; Martens GJM
    Mol Neurobiol; 2020 Feb; 57(2):848-859. PubMed ID: 31493240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
    Seo MH; Yeo S
    Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Ceramide Synthesis Reduces α-Synuclein Proteinopathy in a Cellular Model of Parkinson's Disease.
    Mingione A; Pivari F; Plotegher N; Dei Cas M; Zulueta A; Bocci T; Trinchera M; Albi E; Maglione V; Caretti A; Bubacco L; Paroni R; Bottai D; Ghidoni R; Signorelli P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Alpha-Synuclein RT-QuIC Products Generated by the Olfactory Mucosa of Patients with Parkinson's Disease and Multiple System Atrophy Induce Inflammatory Responses in SH-SY5Y Cells.
    De Luca CMG; Consonni A; Cazzaniga FA; Bistaffa E; Bufano G; Quitarrini G; Celauro L; Legname G; Eleopra R; Baggi F; Giaccone G; Moda F
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa (L-DOPA) attenuates endoplasmic reticulum stress response and cell death signaling through DRD2 in SH-SY5Y neuronal cells under α-synuclein-induced toxicity.
    Song J; Kim BC; Nguyen DT; Samidurai M; Choi SM
    Neuroscience; 2017 Sep; 358():336-348. PubMed ID: 28687316
    [